TerminatedPhase 2NCT00003483

Antineoplaston Therapy in Treating Patients With Meningioma

Studying Meningioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Burzynski Research Institute
Principal Investigator
Stanislaw R. Burzynski, MD, PhD, MD, PHD
Burzynski Research Institute
Intervention
Antineoplaston therapy (Atengenal + Astugenal)(drug)
Enrollment
3 enrolled
Eligibility
18-99 years · All sexes
Timeline
1998 – 2004

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00003483 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma →

← Back to all trials